SHANDONG LINUO PHARMACEUTICAL PACKAGING CO., LTD.

Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Equities

301188

CNE100004YW1

Non-Paper Containers & Packaging

End-of-day quote Shenzhen S.E. Other stock markets 07/05/2026			5-day change	1st Jan Change
26.28 ^CNY	+1.15%		-2.12%	+49.32%

04-22	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-20	Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding	CI

Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025.

Published on 12/15/2025 at 09:25 am GMT

S&P Capital IQ

SHANDONG LINUO PHARMACEUTICAL PACKAGING CO., LTD.

+1.15%

From October 1, 2025 to December 15, 2025, the company has repurchased 1,659,800 shares, representing 0.71% for CNY 29.44 million. With this, the company has completed the repurchase of 4,557,700 shares, representing 1.98% for CNY 81.11 million under the buyback announced on February 7, 2025.

Latest news about Shandong Linuo Pharmaceutical Packaging Co., Ltd.

04-22	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-20	Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding	CI
04-06	Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million.	CI
03-31	Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake	RE
12-15	Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025.	CI
12-14	Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million.	CI
11-03	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections	CI
27/10/25	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
09/10/25	Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025.	CI
28/09/25	Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd.	CI
09/09/25	Shandong Linuo Pharmaceutical Packaging's shareholder to unload shares	RE
20/08/25	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/08/25	Shandong Linuo Pharmaceutical Packaging Co., Ltd. agreed to acquire 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. for CNY 84 million.	CI
07/08/25	Shandong Linuo Pharmaceutical Packaging's shareholders to unload stakes	RE
16/05/25	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Cash Dividend for the Year 2024 on A Shares, Payable on May 29, 2025	CI

Chart Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Duration

Period

Chart Shandong Linuo Pharmaceutical Packaging Co., Ltd.

301188: Dynamic Chart

Company Profile

Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.

Employees

1,446

Sector

Non-Paper Containers & Packaging

More about the company